Invention Grant
- Patent Title: Opioid receptor modulator dosage formulations
-
Application No.: US17175082Application Date: 2021-02-12
-
Publication No.: US11090291B2Publication Date: 2021-08-17
- Inventor: Tim Costello , Jens Jozef Ceulemans , Eugeen Maria Jozef Jans , Philip Erna H. Heyns
- Applicant: Allergan Holdings Unlimited Company
- Applicant Address: IE Dublin
- Assignee: Allergan Holdings Unlimited Company
- Current Assignee: Allergan Holdings Unlimited Company
- Current Assignee Address: IE Dublin
- Agency: Foley Hoag LLP
- Main IPC: A61K31/4174
- IPC: A61K31/4174 ; A61K9/50 ; A61K9/20 ; A61K47/26 ; A61K9/28 ; A61P25/04

Abstract:
Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
Public/Granted literature
- US20210205268A1 OPIOID RECEPTOR MODULATOR DOSAGE FORMULATIONS Public/Granted day:2021-07-08
Information query
IPC分类: